Hong Seng to buy 51% stake in Pow Pocket for RM200mil


From left: Pow Pocket Sdn Bhd Senior Advisor Kuhan Arunasalam, Pow Pocket managing director Russell Walter Boyd, Hong Seng Consolidated Bhd non-executive chairman Datuk Seri Dr Chen Chaw Min, Hong Seng group managing director Datuk Seri Teoh Hai Hin and Hong Seng executive director Lester Chin.

KUALA LUMPUR: Hong Seng Consolidated Bhd’s unit HS Bio Sdn Bhd is buying a 51% stake in Pow Pocket Sdn Bhd for RM200mil cash consideration which plans to roll out a nationwide end-to-end private Covid-19 vaccine programme.

In a statement on Friday, it said Pow Pocket’s programme to be known as “Immunise”, is an open and inclusive platform to capture the demand for booster and juvenile vaccination shots in the country.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Hong Seng , Pow Pocket , HS Bio Supplies , Immunise ,

Next In Business News

Ringgit closes higher against greenback on cautious market sentiment
T7 Global subsidiary appointed panel contractor for PETRONAS
YTL inks RM200mil naming rights deal with Aviva for Bristol arena
KL High Court dismisses appeals of former Jalatama officers
Well Chip posts FY25 net profit jump to RM86.15mil
Angkasa targets 2026 revenue to reach up to RM75bil
Aeon Credit issues RM100mil five-year senior sukuk
Late bargain-hunting lifts Bursa Malaysia to end higher
Net foreign inflows into Malaysian bonds reach RM951.9mil in January - RAM Ratings
Wawasan Dengkil's 2Q net profit falls due to revision of project costs

Others Also Read